Inogene US – advanced technology for molecular diagnostics
Inogene supplies high-quality and professional solutions for oncology and hematology diagnostics. We supply our products to customers worldwide.
Our company provides:
- Regular supply of diagnostic kits and reagents for molecular diagnostics and research
- Competent customer technical support.
- Regular release of newly developed products
- We focus on development of test systems for molecular genetic diagnostics of cancer in order to assess the prognosis of disease and the effectiveness of therapy.
We offer Kits for:
- the study of genetic factors associated with the likelihood of ovarian cancer and breast cancer development
- analysis of genetic factors that determine the course and prognosis of acute leukemia
- analysis of molecular markers that determine sensitivity to therapy ( for lung cancer and chronic myeloid leukemia)
- assessment of minimal residual disease (MRD) in acute and chronic myeloid leukemia
- assessment of donor cells engraftment - donor chimerism (during hematopoietic stem cell transplantation). This system can also be used in the investigation of the kinship existence
The developed test system is adapted for use with a capillary sequencer and the devices with the detection of the amplification products in real time, with respect to most available diagnostic laboratories now quite common.
Our advantages
- ability to adapt the test systems for any equipment (fluorescent Real-time PCR amplifiers, Sanger sequencers)
- ability to conduct training for working with the test systems, including on-site at the customer's laboratory
- possible development of a custom test system
Main Activity
- Developing, manufacturing and distribution of reagents for diagnostics & Life Science
- Marketing and promotion of the products from the company portfolio
- Customer training and support
Company Philosophy
We do not simply sale Kits - we support the implementation of new tests and accompanying methodology with results in focus.